Prevalence of osteoporosis in Chinese postmenopausal females: a meta-analysis_Chinese Journal of Evidence-Based Medicine

Authors：

WU Huiyi ¹ , LIU Ying ² , LAN Yajia ^1,3 ,  ZHONG Jiao ⁴

1. Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, P. R. China;
2. West China School of Medicine and West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
3. Department of Occupational and Environmental Health, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, P. R. China;
4. Department of Osteoporosis, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, P. R. China;

Corresponding author：

ZHONG Jiao, Email: 79170224@qq.com

Keywords：

China; Postmenopausal female; Osteoporosis; Prevalence; Meta-analysis

DOI：

10.7507/1672-2531.202204036

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To systematically review the prevalence of osteoporosis (OP) in Chinese postmenopausal females. Methods The CNKI, VIP, CBM, WanFang Data, PubMed, EMbase and The Cochrane Library databases were electronically searched to collect studies on the prevalence of OP in Chinese postmenopausal females from inception to March 17^th, 2022. Two reviewers independently screened the literature, extracted data and evaluated the risk of bias of the included studies. Meta-analysis was then performed using Stata 14.0 software. Results A total of 54 studies involving 96 391 cases and 41 651 confirmed OP patients were included. The meta-analysis results showed that the prevalence of OP in Chinese postmenopausal females was 38.8% (95%CI 34.1% to 43.5%). Subgroup analysis showed that the prevalence of OP was 31.7% (95%CI 16.6% to 48.6%) in females who had been menopausal for less than 5 years, 47.4% (95%CI 32.2% to 62.5%) for 5-9 years, 52.7% (95%CI 37.1% to 68.3%) for 10-14 years, 77.5% (95%CI 69.5% to 85.4%) for 15-19 years, and 78.3% (95%CI 56.3% to 100.0%) for more than 20 years. The rate was 16.2% (95%CI 28.8% to 37.2%) in under 50 years age group, 28.8% (95%CI 34.4% to 47.9%) for 50- years group, 41.1% (95%CI 34.4% to 47.9%) for 60- years group, 55.3% (95%CI 45.8% to 64.8%) for 70- years group, 82.0% (95%CI 76.1% to 87.9%) for 80- years group. The prevalence in different regions was between 31.0% and 43.5%, which was lowest in the northeast (31.0%, 95%CI 26.3% to 51.4%) and highest in the northwest (43.5%, 95%CI 22.3% to 64.7%). According to the year of publication, the rate was 43.9% (95%CI 15.7% to 72.0%) from 1997 to 2009 and 38.2% (95%CI 33.8% to 42.5%) from 2010 to 2021. The prevalence of OP was 24.9% (95%CI 20.5% to 29.3%) in postmenopausal females with no birth or 1 birth, and 45.0% (95%CI 37.0% to 53.0%) in females with 2 or more births. Conclusion The prevalence of OP in Chinese postmenopausal females is relatively high. Due to the limited quantity and quality of the included studies, more high-quality studies are needed to verify the above conclusion.

Citation： WU Huiyi, LIU Ying, LAN Yajia, ZHONG Jiao. Prevalence of osteoporosis in Chinese postmenopausal females: a meta-analysis. Chinese Journal of Evidence-Based Medicine, 2022, 22(8): 882-890. doi: 10.7507/1672-2531.202204036 Copy

1.	Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol, 2006, 194(Suppl 2): S3-11.
2.	中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017版). 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-444.
3.	Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci, 2013, 68(10): 1243-1251.
4.	Wang L, Yu W, Yin X, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open, 2021, 4(8): e2121106.
5.	薛昊罡, 冷冰, 马恩元, 等. 吉林市绝经后女性骨质疏松发病情况调查. 现代预防医学, 2011, 38(20): 4135-4137.
6.	贺丽英, 孙蕴, 要文娟, 等. 2010-2016年中国老年人骨质疏松症患病率Meta分析. 中国骨质疏松杂志, 2016, 22(12): 1590-1596.
7.	朱洁云, 高敏, 宋秋韵, 等. 中国老年人骨质疏松症患病率的Meta分析. 中国全科医学, 2022, 25(3): 346-353.
8.	曾宪涛, 刘慧, 陈曦, 等. Meta分析系列之四: 观察性研究的质量评价工具. 中国循证心血管医学杂志, 2012, 4(4): 297-299.
9.	安永东, 蔡兴魁, 杨英, 等. 甘肃省临夏地区绝经女性和老年男性骨质疏松流行病学调查及相关危险因素分析. 临床医药文献电子杂志, 2017, 4(92): 18187-18188.
10.	刘顺智, 颜虹, 许鹏, 等. 西安市城区绝经后妇女骨密度与女性生理因素的相关性. 西安交通大学学报(医学版), 2008, 29(1): 106-109.
11.	马先富, 黄振武, 杨晓光, 等. 基于logistic模型对影响绝经期妇女骨质疏松症的动物性饮食因素研究. 中国卫生统计, 2012, 29(2): 206-209, 213.
12.	王亚南, 侯钦午, 蔡燕明, 等. 绝经后女性不同部位骨密度检测结果分析. 中国初级卫生保健, 2021, 35(11): 59-61.
13.	许卫东, 王涛, 沈江. 德清地区绝经期女性骨质疏松患病情况及其影响因素分析. 中国妇幼保健, 2020, 35(10): 1870-1873.
14.	Li S, Zhan J, Wang Y, et al. Association between renal function and bone mineral density in healthy postmenopausal Chinese women. BMC Endocr Disord, 2019, 19(1): 146.
15.	Lo SS. Bone health status of postmenopausal Chinese women. Hong Kong Med J, 2015, 21(6): 536-541.
16.	Ma Y, Li X, Zhang H, et al. Serum myostatin in central south Chinese postmenopausal women: relationship with body composition, lipids and bone mineral density. Endocr Res, 2016, 41(3): 223-228.
17.	黄定贵, 黄国秀, 闭应洲, 等. 南宁地区20899名壮族, 汉族正常人群峰值骨量和年龄相关骨丢失的临床意义. 中国骨质疏松杂志, 2017, 23(11): 1507-1511.
18.	龙贵平, 王茹. 健康体检骨密度测定4856例分析. 中国保健营养(中旬刊), 2012, (8): 394-394.
19.	彭茸, 张海燕, 周文正, 等. 重庆市2805例健康女性DXA法骨密度现况分析. 重庆医科大学学报, 2019, 44(3): 356-359.
20.	宋卫红, 李梦阳. 郴州市社区女性骨骼健康现状调查研究. 湘南学院学报(医学版), 2010, 12(1): 45-47.
21.	Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr, 2006, 83(1): 146-154.
22.	Yan DD, Wang J, Hou XH, et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin, 2018, 39(4): 626-632.
23.	蔡程芳, 淦细红, 陈和珍, 等. 温州地区绝经后老年女性骨质疏松的患病率及其危险因素分析. 全科医学临床与教育, 2018, 16(4): 388-391, 413.
24.	陈侠, 陈琰琰, 林仲可. 绝经后老年女性骨质疏松与肌肉力量和肌肉含量的相关性研究. 护士进修杂志, 2019, 34(3): 207-210.
25.	程国钧, 袁艺, 刘建立, 等. 北京市城区1400例妇女腰椎骨量与年龄和绝经的关系. 中华妇产科杂志, 1997, 32(9): 532-534.
26.	顾巧萍, 吴丽平, 孙微. 绝经后骨质疏松症的患病率及危险因素研究. 中国妇幼保健, 2020, 35(22): 4158-4162.
27.	叶竹, 黄宏兴, 付丰平, 等. 广东省女性绝经后原发性骨质疏松症调查分析. 中国骨质疏松杂志, 2012, 18(4): 344-346, 353.
28.	蒋红岩, 申浩, 魏戌, 等. 北京市长辛店地区绝经后女性骨量状态与骨代谢相关指标的关系. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14(2): 148-152.
29.	蒋燕飞. 女性绝经后发生骨质疏松症的危险因素及其预防措施分析. 中国妇幼保健, 2021, 36(12): 2857-2859.
30.	李茂蓉, 黄薇, 欧小虹, 等. 绝经后非糖尿病妇女骨质疏松症影响因素的Logistic回归和ROC曲线分析. 中国骨质疏松杂志, 2016, 22(5): 540-544.
31.	梁莉, 马子涵, 杨来虎, 等. 甘肃省兰州地区中老年女性骨密度现状调查及危险因素分析. 中国骨质疏松杂志, 2020, 26(11): 1685-1688.
32.	林彦杰, 李勇峰, 王辉辉. 非糖尿病女性绝经后骨质疏松发生率及其独立危险因素分析. 中国民康医学, 2017, 29(19): 19-21.
33.	罗采南, 石亚妹, 米克拉依, 等. 乌鲁木齐城市和农村绝经后妇女血清维生素D与骨质疏松状况调查. 中国骨质疏松杂志, 2018, 24(7): 940-943.
34.	马晓庆, 司广新, 王倩. 济宁市健康体检人群>50岁男性和绝经后女性骨质疏松及维生素D水平分析. 社区医学杂志, 2020, 18(1): 20-23.
35.	杨华, 程昌志, 罗远国, 等. 广西地区绝经后妇女骨密度影响因素分析. 西部医学, 2014, 26(11): 1504-1506.
36.	杨永碧. 绝经期女性骨质疏松及其影响因素. 中国老年学杂志, 2014, (11): 3176-3177, 3178.
37.	袁园, 周燕清, 於元. 咖啡饮品对绝经女性骨质疏松防治的影响. 中国妇幼保健, 2016, 31(19): 3990-3992.
38.	Chai H, Ge J, Li L, et al. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord, 2021, 22(1): 253.
39.	Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporosis, 2017, 12(1): 50.
40.	Li XS, Zhang JR, Meng SY, et al. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab, 2012, 30(6): 660-665.
41.	Sheng Z, Xu K, Ou Y, et al. Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf), 2011, 74(3): 319-324.
42.	Zhao YX, Song YW, Zhang L, et al. Association between bile acid metabolism and bone mineral density in postmenopausal women. Clinics (Sao Paulo), 2020, 75: e1486.
43.	王剑, 鲁敏, 孙官文, 等. 呼和浩特地区40~65岁中老年女性骨质疏松症的流行现状及相关因素分析. 中国医药, 2020, 15(4): 601-605.
44.	张珍珍, 李李. 皖北地区40~65岁女性骨质疏松的危险因素调查. 中国老年学杂志, 2017, 37(8): 2042-2045.
45.	曾玉红, 刘峰, 张斌, 等. 2964例女性原发性骨质疏松检出率分析. 中华老年医学杂志, 2007, 26(9): 704-705.
46.	丘红, 曾玉红, 闫富梅, 等. 女性原发性骨质疏松患病率及易患因素的初步研究. 中国煤炭工业医学杂志, 2008, 11(6): 831-832.
47.	王俊, 王雪君, 方贞. 城区中老年女性骨质疏松影响因素分析. 中国慢性病预防与控制, 2017, 25(4): 273-276.
48.	毛未贤, 张萌萌, 马倩倩, 等. 长春地区女性骨密度与年龄、绝经年限、体重指数的相关性研究. 中国骨质疏松杂志, 2016, 22(9): 1083-1086.
49.	He Y, Huang J, Jiang G, et al. Menarche age exceed 17 years and menopausal age smaller than 48 years may affect prevalence of osteoporosis for Chinese women. Arch Osteoporos, 2021, 16(1): 123.
50.	郭华平, 郁嫣嫣, 陈文华, 等. 绝经后骨质疏松症发病相关危险因素分析及预防措施探讨. 中国康复医学杂志, 2011, 26(5): 424-428.
51.	毛小明. 绝经妇女骨密度, 肌肉脂肪含量与骨质疏松的关系. 齐齐哈尔医学院学报, 2017, 38(20): 2436-2438.
52.	秦宝莹, 顾本进, 汤美秀. 江苏地区3年间绝经女性患骨质疏松症影响因素分析. 临床军医杂志, 2019, 47(6): 634-635, 637.
53.	谈佳, 向和东, 覃素娇, 等. 广西壮族与汉族绝经后女性骨密度及骨质疏松症患病率调查分析. 广东医学, 2018, 39(11): 1723-1725.
54.	覃素娇, 罗颖华, 罗珍玉, 等. 广西南宁市区绝经后女性骨质疏松症流行情况及相关因素研究. 中国骨质疏松杂志, 2017, 23(7): 942-946.
55.	田利民, 杨睿斐, 魏莲花, 等. 甘肃省绝经女性和老年男性骨质疏松流行病学调查及相关影响因素分析. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(2): 142-148.
56.	王奔, 林乾, 韩栋, 等. 绝经后女性骨质疏松危险因素分析. 中国慢性病预防与控制, 2021, 29(7): 510-513.
57.	郭贵华, 李颖, 彭玉兰, 等. 黔南地区农村≥40岁女性居民绝经后骨质疏松症患病率调查. 饮食保健, 2021, (5): 274-275.
58.	李漫馥, 齐俊婷, 张靖唯. 葫芦岛市龙港区绝经后妇女骨质疏松症患病现状及其影响因素. 中国卫生工程学, 2021, 20(5): 763-765.
59.	刘付国杰, 朱国华, 李裕汉. 茂名地区绝经后女性骨密度调查及不同部位检出率研究. 中国医学创新, 2017, 14(13): 72-75.
60.	余建国, 姚安晋, 张东, 等. 绝经后骨质疏松症腰椎骨密度研究. 实用放射学杂志, 2000, 16(1): 35-36.
61.	Li S, Guo H, Liu Y, et al. Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women. Clin Endocrinol (Oxf), 2015, 82(1): 53-58.
62.	Eghbali T, Abdi K, Nazari M, et al. Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord, 2022, 15: 11795441211072471.
63.	Baccaro LF, Conde DM, Costa-Paiva L, et al. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging, 2015, 10: 583-591.
64.	Thulkar J, Singh S, Sharma S, et al. Preventable risk factors for osteoporosis in postmenopausal women: systematic review and meta-analysis. J Midlife Health, 2016, 7(3): 108-113.
65.	胡伟雄, 林涌鹏, 饶思远, 等. 814例绝经后女性初潮年龄, 绝经年龄及月经维持年限与骨质疏松症相关性研究. 中国骨质疏松杂志, 2020, 26(9): 1257-1261.

1. Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol, 2006, 194(Suppl 2): S3-11.
2. 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017版). 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-444.
3. Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci, 2013, 68(10): 1243-1251.
4. Wang L, Yu W, Yin X, et al. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open, 2021, 4(8): e2121106.
5. 薛昊罡, 冷冰, 马恩元, 等. 吉林市绝经后女性骨质疏松发病情况调查. 现代预防医学, 2011, 38(20): 4135-4137.
6. 贺丽英, 孙蕴, 要文娟, 等. 2010-2016年中国老年人骨质疏松症患病率Meta分析. 中国骨质疏松杂志, 2016, 22(12): 1590-1596.
7. 朱洁云, 高敏, 宋秋韵, 等. 中国老年人骨质疏松症患病率的Meta分析. 中国全科医学, 2022, 25(3): 346-353.
8. 曾宪涛, 刘慧, 陈曦, 等. Meta分析系列之四: 观察性研究的质量评价工具. 中国循证心血管医学杂志, 2012, 4(4): 297-299.
9. 安永东, 蔡兴魁, 杨英, 等. 甘肃省临夏地区绝经女性和老年男性骨质疏松流行病学调查及相关危险因素分析. 临床医药文献电子杂志, 2017, 4(92): 18187-18188.
10. 刘顺智, 颜虹, 许鹏, 等. 西安市城区绝经后妇女骨密度与女性生理因素的相关性. 西安交通大学学报(医学版), 2008, 29(1): 106-109.
11. 马先富, 黄振武, 杨晓光, 等. 基于logistic模型对影响绝经期妇女骨质疏松症的动物性饮食因素研究. 中国卫生统计, 2012, 29(2): 206-209, 213.
12. 王亚南, 侯钦午, 蔡燕明, 等. 绝经后女性不同部位骨密度检测结果分析. 中国初级卫生保健, 2021, 35(11): 59-61.
13. 许卫东, 王涛, 沈江. 德清地区绝经期女性骨质疏松患病情况及其影响因素分析. 中国妇幼保健, 2020, 35(10): 1870-1873.
14. Li S, Zhan J, Wang Y, et al. Association between renal function and bone mineral density in healthy postmenopausal Chinese women. BMC Endocr Disord, 2019, 19(1): 146.
15. Lo SS. Bone health status of postmenopausal Chinese women. Hong Kong Med J, 2015, 21(6): 536-541.
16. Ma Y, Li X, Zhang H, et al. Serum myostatin in central south Chinese postmenopausal women: relationship with body composition, lipids and bone mineral density. Endocr Res, 2016, 41(3): 223-228.
17. 黄定贵, 黄国秀, 闭应洲, 等. 南宁地区20899名壮族, 汉族正常人群峰值骨量和年龄相关骨丢失的临床意义. 中国骨质疏松杂志, 2017, 23(11): 1507-1511.
18. 龙贵平, 王茹. 健康体检骨密度测定4856例分析. 中国保健营养(中旬刊), 2012, (8): 394-394.
19. 彭茸, 张海燕, 周文正, 等. 重庆市2805例健康女性DXA法骨密度现况分析. 重庆医科大学学报, 2019, 44(3): 356-359.
20. 宋卫红, 李梦阳. 郴州市社区女性骨骼健康现状调查研究. 湘南学院学报(医学版), 2010, 12(1): 45-47.
21. Hsu YH, Venners SA, Terwedow HA, et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr, 2006, 83(1): 146-154.
22. Yan DD, Wang J, Hou XH, et al. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin, 2018, 39(4): 626-632.
23. 蔡程芳, 淦细红, 陈和珍, 等. 温州地区绝经后老年女性骨质疏松的患病率及其危险因素分析. 全科医学临床与教育, 2018, 16(4): 388-391, 413.
24. 陈侠, 陈琰琰, 林仲可. 绝经后老年女性骨质疏松与肌肉力量和肌肉含量的相关性研究. 护士进修杂志, 2019, 34(3): 207-210.
25. 程国钧, 袁艺, 刘建立, 等. 北京市城区1400例妇女腰椎骨量与年龄和绝经的关系. 中华妇产科杂志, 1997, 32(9): 532-534.
26. 顾巧萍, 吴丽平, 孙微. 绝经后骨质疏松症的患病率及危险因素研究. 中国妇幼保健, 2020, 35(22): 4158-4162.
27. 叶竹, 黄宏兴, 付丰平, 等. 广东省女性绝经后原发性骨质疏松症调查分析. 中国骨质疏松杂志, 2012, 18(4): 344-346, 353.
28. 蒋红岩, 申浩, 魏戌, 等. 北京市长辛店地区绝经后女性骨量状态与骨代谢相关指标的关系. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14(2): 148-152.
29. 蒋燕飞. 女性绝经后发生骨质疏松症的危险因素及其预防措施分析. 中国妇幼保健, 2021, 36(12): 2857-2859.
30. 李茂蓉, 黄薇, 欧小虹, 等. 绝经后非糖尿病妇女骨质疏松症影响因素的Logistic回归和ROC曲线分析. 中国骨质疏松杂志, 2016, 22(5): 540-544.
31. 梁莉, 马子涵, 杨来虎, 等. 甘肃省兰州地区中老年女性骨密度现状调查及危险因素分析. 中国骨质疏松杂志, 2020, 26(11): 1685-1688.
32. 林彦杰, 李勇峰, 王辉辉. 非糖尿病女性绝经后骨质疏松发生率及其独立危险因素分析. 中国民康医学, 2017, 29(19): 19-21.
33. 罗采南, 石亚妹, 米克拉依, 等. 乌鲁木齐城市和农村绝经后妇女血清维生素D与骨质疏松状况调查. 中国骨质疏松杂志, 2018, 24(7): 940-943.
34. 马晓庆, 司广新, 王倩. 济宁市健康体检人群>50岁男性和绝经后女性骨质疏松及维生素D水平分析. 社区医学杂志, 2020, 18(1): 20-23.
35. 杨华, 程昌志, 罗远国, 等. 广西地区绝经后妇女骨密度影响因素分析. 西部医学, 2014, 26(11): 1504-1506.
36. 杨永碧. 绝经期女性骨质疏松及其影响因素. 中国老年学杂志, 2014, (11): 3176-3177, 3178.
37. 袁园, 周燕清, 於元. 咖啡饮品对绝经女性骨质疏松防治的影响. 中国妇幼保健, 2016, 31(19): 3990-3992.
38. Chai H, Ge J, Li L, et al. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord, 2021, 22(1): 253.
39. Han W, Bai X, Wang N, et al. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Arch Osteoporosis, 2017, 12(1): 50.
40. Li XS, Zhang JR, Meng SY, et al. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab, 2012, 30(6): 660-665.
41. Sheng Z, Xu K, Ou Y, et al. Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf), 2011, 74(3): 319-324.
42. Zhao YX, Song YW, Zhang L, et al. Association between bile acid metabolism and bone mineral density in postmenopausal women. Clinics (Sao Paulo), 2020, 75: e1486.
43. 王剑, 鲁敏, 孙官文, 等. 呼和浩特地区40~65岁中老年女性骨质疏松症的流行现状及相关因素分析. 中国医药, 2020, 15(4): 601-605.
44. 张珍珍, 李李. 皖北地区40~65岁女性骨质疏松的危险因素调查. 中国老年学杂志, 2017, 37(8): 2042-2045.
45. 曾玉红, 刘峰, 张斌, 等. 2964例女性原发性骨质疏松检出率分析. 中华老年医学杂志, 2007, 26(9): 704-705.
46. 丘红, 曾玉红, 闫富梅, 等. 女性原发性骨质疏松患病率及易患因素的初步研究. 中国煤炭工业医学杂志, 2008, 11(6): 831-832.
47. 王俊, 王雪君, 方贞. 城区中老年女性骨质疏松影响因素分析. 中国慢性病预防与控制, 2017, 25(4): 273-276.
48. 毛未贤, 张萌萌, 马倩倩, 等. 长春地区女性骨密度与年龄、绝经年限、体重指数的相关性研究. 中国骨质疏松杂志, 2016, 22(9): 1083-1086.
49. He Y, Huang J, Jiang G, et al. Menarche age exceed 17 years and menopausal age smaller than 48 years may affect prevalence of osteoporosis for Chinese women. Arch Osteoporos, 2021, 16(1): 123.
50. 郭华平, 郁嫣嫣, 陈文华, 等. 绝经后骨质疏松症发病相关危险因素分析及预防措施探讨. 中国康复医学杂志, 2011, 26(5): 424-428.
51. 毛小明. 绝经妇女骨密度, 肌肉脂肪含量与骨质疏松的关系. 齐齐哈尔医学院学报, 2017, 38(20): 2436-2438.
52. 秦宝莹, 顾本进, 汤美秀. 江苏地区3年间绝经女性患骨质疏松症影响因素分析. 临床军医杂志, 2019, 47(6): 634-635, 637.
53. 谈佳, 向和东, 覃素娇, 等. 广西壮族与汉族绝经后女性骨密度及骨质疏松症患病率调查分析. 广东医学, 2018, 39(11): 1723-1725.
54. 覃素娇, 罗颖华, 罗珍玉, 等. 广西南宁市区绝经后女性骨质疏松症流行情况及相关因素研究. 中国骨质疏松杂志, 2017, 23(7): 942-946.
55. 田利民, 杨睿斐, 魏莲花, 等. 甘肃省绝经女性和老年男性骨质疏松流行病学调查及相关影响因素分析. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(2): 142-148.
56. 王奔, 林乾, 韩栋, 等. 绝经后女性骨质疏松危险因素分析. 中国慢性病预防与控制, 2021, 29(7): 510-513.
57. 郭贵华, 李颖, 彭玉兰, 等. 黔南地区农村≥40岁女性居民绝经后骨质疏松症患病率调查. 饮食保健, 2021, (5): 274-275.
58. 李漫馥, 齐俊婷, 张靖唯. 葫芦岛市龙港区绝经后妇女骨质疏松症患病现状及其影响因素. 中国卫生工程学, 2021, 20(5): 763-765.
59. 刘付国杰, 朱国华, 李裕汉. 茂名地区绝经后女性骨密度调查及不同部位检出率研究. 中国医学创新, 2017, 14(13): 72-75.
60. 余建国, 姚安晋, 张东, 等. 绝经后骨质疏松症腰椎骨密度研究. 实用放射学杂志, 2000, 16(1): 35-36.
61. Li S, Guo H, Liu Y, et al. Relationships of serum lipid profiles and bone mineral density in postmenopausal Chinese women. Clin Endocrinol (Oxf), 2015, 82(1): 53-58.
62. Eghbali T, Abdi K, Nazari M, et al. Prevalence of osteoporosis among Iranian postmenopausal women: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord, 2022, 15: 11795441211072471.
63. Baccaro LF, Conde DM, Costa-Paiva L, et al. The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil. Clin Interv Aging, 2015, 10: 583-591.
64. Thulkar J, Singh S, Sharma S, et al. Preventable risk factors for osteoporosis in postmenopausal women: systematic review and meta-analysis. J Midlife Health, 2016, 7(3): 108-113.
65. 胡伟雄, 林涌鹏, 饶思远, 等. 814例绝经后女性初潮年龄, 绝经年龄及月经维持年限与骨质疏松症相关性研究. 中国骨质疏松杂志, 2020, 26(9): 1257-1261.

Chinese Journal of Evidence-Based Medicine

Prevalence of osteoporosis in Chinese postmenopausal females: a meta-analysis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content